主页 > 医学信息 >

【medical-news】NEJM:发现SLE易感基因新位点

Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX

ABSTRACT

Background
Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in which the risk of disease is influenced by complex genetic and environmental contributions. Alleles of HLA-DRB1, IRF5, and STAT4 are established susceptibility genes; there is strong evidence for the existence of additional risk loci.

Methods
We genotyped more than 500,000 single-nucleotide polymorphisms (SNPs) in DNA samples from 1311 case subjects with SLE and 1783 control subjects; all subjects were North Americans of European descent. Genotypes from 1557 additional control subjects were obtained from public data repositories. We measured the association between the SNPs and SLE after applying strict quality-control filters to reduce technical artifacts and to correct for the presence of population stratification. Replication of the top loci was performed in 793 case subjects and 857 control subjects from Sweden.

Results
Genetic variation in the region upstream from the transcription initiation site of the gene encoding B lymphoid tyrosine kinase (BLK) and C8orf13 (chromosome 8p23.1) was associated with disease risk in both the U.S. and Swedish case–control series (rs13277113; odds ratio, 1.39; P=1x10–10) and also with altered levels of messenger RNA in B-cell lines. In addition, variants on chromosome 16p11.22, near the genes encoding integrin alpha M (ITGAM, or CD11b) and integrin alpha X (ITGAX), were associated with SLE in the combined sample (rs11574637; odds ratio, 1.33; P=3x10–11).

Conclusions
We identified and then confirmed through replication two new genetic loci for SLE: a promoter-region allele associated with reduced expression of BLK and increased expression of C8orf13 and variants in the ITGAM–ITGAX region

http://content.nejm.org/cgi/content/short/358/9/900 本人已认领该文,24小时后若未提交译文,请其他战友自由认领。 Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
系统性红斑狼疮与C8orf13–BLK 、ITGAM–ITGAX的关联

ABSTRACT
摘要

Background
背景

Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in which the risk of disease is influenced by complex genetic and environmental contributions. Alleles of HLA-DRB1, IRF5, and STAT4 are established susceptibility genes; there is strong evidence for the existence of additional risk loci.
系统性红斑狼疮是一种异质性疾病,其发病风险受多基因和环境因素影响。现已确定等位基因HLA-DRB1, IRF5和 STAT4是SLE的易感基因,有证据强烈提示了其他风险位点的存在。

Methods
方法

We genotyped more than 500,000 single-nucleotide polymorphisms (SNPs) in DNA samples from 1311 case subjects with SLE and 1783 control subjects; all subjects were North Americans of European descent.
我们对来自1311位SLE患者和1783位健康对照者的DNA中超过500,000个单核苷酸多态(SNPs)进行基因研究,所有受检者均来自欧洲后裔的北美人。

Genotypes from 1557 additional control subjects were obtained from public data repositories.
另外1557个对照组基因型由公共数据库提供。

We measured the association between the SNPs and SLE after applying strict quality-control filters to reduce technical artifacts and to correct for the presence of population stratification.
为了减少技术上的误差和纠正人群层次,我们在严格筛选病例组后检测了SNPs和SLE之间的相关性。

Replication of the top loci was performed in 793 case subjects and 857 control subjects from Sweden.
我们复制了来自瑞典的793个病例和857个对照的主要位点。

Results
结果

Genetic variation in the region upstream from the transcription initiation site of the gene encoding B lymphoid tyrosine kinase (BLK) and C8orf13 (chromosome 8p23.1) was associated with disease risk in both the U.S. and Swedish case–control series (rs13277113; odds ratio, 1.39; P=1x10–10) and also with altered levels of messenger RNA in B-cell lines.
编码B淋巴酪氨酸激酶(BLK)和C8orf13(染色体8p23.1)的转录起始位点上游基因的变异与美国和瑞典病例组及对照组的疾病风险均有关联(rs13277113;机会比率,1.39;P=1x10–10),也与B细胞系中信使RNA的变异水平相关联。
In addition, variants on chromosome 16p11.22, near the genes encoding integrin alpha M (ITGAM, or CD11b) and integrin alpha X (ITGAX), were associated with SLE in the combined sample (rs11574637; odds ratio, 1.33; P=3x10–11).
此外,在所有样品中,位于编码整合素α M (ITGAM或CD11b)和整合素α X (ITGAX)附近的染色体16p11.22的变异与SLE相关联(rs11574637; 机会比率, 1.33; P=3x10–11).

Conclusions
结论

We identified and then confirmed through replication two new genetic loci for SLE: a promoter-region allele associated with reduced expression of BLK and increased expression of C8orf13 and variants in the ITGAM–ITGAX region.

阅读本文的人还阅读:

特定基因变异与心脏病和

将所有肿瘤基因进行分类

心绞痛基因疗法注入去毒

【Oncogene编译】确认的新

FOXP2基因与发声能

作者:admin@医学,生命科学    2011-04-23 05:14
医学,生命科学网